Abstract
Case Report: A patient with residual craniopharyngioma experienced a rapid tumor relapse during growth hormone therapy. Objective: We present this case and remind physicians that it is necessary to reevaluate the safety of growth hormone therapy in patients with residual craniopharyngioma.
Original language | English |
---|---|
Pages (from-to) | 164-165 |
Number of pages | 2 |
Journal | Child's Nervous System |
Volume | 18 |
Issue number | 3-4 |
DOIs | |
Publication status | Published - Apr 2002 |
Externally published | Yes |
Keywords
- Craniopharyngioma
- Growth hormone
- Rapid growth
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Clinical Neurology